Imagine a medical product that’s a “living skin equivalent.” It peels off a roll, like Scotch tape, ready for immediate use. Science fiction? No, it’s science fact. What’s more, this product can heal chronic, life threatening wounds that competing products can’t. Now imagine investing early in the company that makes this revolutionary remedy: Osiris Therapeutics, a leader in the development and commercialization of several products that incorporate stem cells to treat chronic wounds. With Osiris’ products, the potential to save lives is enormous. For investors, the potential to make money is enormous, too. Read on to get more information about Osiris, as well as the latest updates on previous recommendations.
